Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain
- First Posted Date
- 2021-03-03
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Eliem Therapeutics (UK) Ltd.
- Target Recruit Count
- 149
- Registration Number
- NCT04778592
- Locations
- 🇺🇸
Delta Clinical Research, Mobile, Alabama, United States
🇺🇸Arizona Research Center, Phoenix, Arizona, United States
🇺🇸DBPS Research LLC, Greenwood Village, Colorado, United States
Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain
Phase 2
Completed
- Conditions
- Diabetic Peripheral Neuropathic PainDiabetic Peripheral Neuropathy
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-12-30
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Eliem Therapeutics (UK) Ltd.
- Target Recruit Count
- 167
- Registration Number
- NCT04688671
- Locations
- 🇺🇸
Delta Clinical Research, Mobile, Alabama, United States
🇺🇸Arizona Research Center, Phoenix, Arizona, United States
🇺🇸Neuro-Pain Medical Cneter, Fresno, California, United States
News
No news found